NEW YORK and FRANKFURT; Aug. 3, 2010 – In 2011, 40 percent of the highest-selling drugs will be products whose patent protection has either already expired or will do so in the coming two years, according to an analysis by Accenture (NYSE: ACN). In 2007, the share of such so-called mature products accounted for only 15 percent of the portfolios of pharmaceutical companies.
NEW YORK; September 10, 2008– Accenture (NYSE: ACN) announced today that it has signed a new 10-year, $550 million agreement with Bristol-Myers Squibb for a range of finance and accounting and application development and maintenance services.
U.S. consumers trust the Internet nearly as much as they do pharmacists as a resource from which to learn about medications, according to the results of a survey released today by Accenture (NYSE:ACN).
In light of recent prescription drug recalls, physicians and consumers alike are concerned about drug safety, agreeing that more should be done to monitor drugs for side effects after they are approved for market to ensure their safe use, according to results of a study released today by Accenture (NYSE: ACN).
Accenture announced results from tests run by a group of pharmaceutical manufacturers, distributors and retailers exploring the application of electronic product code (EPC) and radio frequency identification (RFID) technologies across the pharmaceutical supply chain.
We were unable to find a match for \"$searchstring.\" Try searching again by using different or more general keywords and check for spelling errors.
You must be logged in to view this item.
This area is reserved for members of the news media. If you qualify, please update your user profile and check the box marked "Check here to register as an accredited member of the news media". Please include any notes in the "Supporting information for media credentials" box. We will notify you of your status via e-mail in one business day.